Issue navigation
Volume 116, Issue 3, March 2024
Editorials
A new initiative for the Journal of the National Cancer Institute: supporting early career investigators
Mark E Sherman and others
JNCI: Journal of the National Cancer Institute, Volume 116, Issue 3, March 2024, Pages 341–342, https://doi.org/10.1093/jnci/djae015
Beyond survival: a closer look at lead-time bias and disease-free intervals in mammography screening
Christoph I Lee and Joann G Elmore
JNCI: Journal of the National Cancer Institute, Volume 116, Issue 3, March 2024, Pages 343–344, https://doi.org/10.1093/jnci/djad254
Commentaries
A roadmap to establishing global oncology as a priority initiative within a National Cancer Institute–designated cancer center
Katherine Van Loon and others
JNCI: Journal of the National Cancer Institute, Volume 116, Issue 3, March 2024, Pages 345–351, https://doi.org/10.1093/jnci/djad255
Cancer survivorship—a framework for quality cancer care
Bradley Zebrack
JNCI: Journal of the National Cancer Institute, Volume 116, Issue 3, March 2024, Pages 352–355, https://doi.org/10.1093/jnci/djad266
Review
The impact of multidisciplinary cancer conferences on overall survival: a meta-analysis
Ryan S Huang and others
JNCI: Journal of the National Cancer Institute, Volume 116, Issue 3, March 2024, Pages 356–369, https://doi.org/10.1093/jnci/djad268
Articles
Method of primary breast cancer detection and the disease-free interval, adjusting for lead time
Linda de Munck and others
JNCI: Journal of the National Cancer Institute, Volume 116, Issue 3, March 2024, Pages 370–378, https://doi.org/10.1093/jnci/djad230
Exposure to polycyclic aromatic hydrocarbons, volatile organic compounds, and tobacco-specific nitrosamines and incidence of esophageal cancer
Arash Etemadi and others
JNCI: Journal of the National Cancer Institute, Volume 116, Issue 3, March 2024, Pages 379–388, https://doi.org/10.1093/jnci/djad218
Poliovirus receptor–based chimeric antigen receptor T cells combined with NK-92 cells exert potent activity against glioblastoma
Changqing Pan and others
JNCI: Journal of the National Cancer Institute, Volume 116, Issue 3, March 2024, Pages 389–400, https://doi.org/10.1093/jnci/djad226
Sex differences in cancer incidence among solid organ transplant recipients
Sarah S Jackson and others
JNCI: Journal of the National Cancer Institute, Volume 116, Issue 3, March 2024, Pages 401–407, https://doi.org/10.1093/jnci/djad224
Dyslipidemia and cardiovascular disease among childhood cancer survivors: a St. Jude Lifetime Cohort report
Jason F Goldberg and others
JNCI: Journal of the National Cancer Institute, Volume 116, Issue 3, March 2024, Pages 408–420, https://doi.org/10.1093/jnci/djad222
Loss of feedback regulation between FAM3B and androgen receptor driving prostate cancer progression
Tianfang Ma and others
JNCI: Journal of the National Cancer Institute, Volume 116, Issue 3, March 2024, Pages 421–433, https://doi.org/10.1093/jnci/djad215
Actigraphy-derived measures of sleep and risk of prostate cancer in the UK Biobank
Joshua R Freeman and others
JNCI: Journal of the National Cancer Institute, Volume 116, Issue 3, March 2024, Pages 434–444, https://doi.org/10.1093/jnci/djad210
Mental health outcomes in a population-based cohort of patients with prostate cancer
Siqi Hu and others
JNCI: Journal of the National Cancer Institute, Volume 116, Issue 3, March 2024, Pages 445–454, https://doi.org/10.1093/jnci/djad175
Impact of pain and adverse health outcomes on long-term US testicular cancer survivors
Paul C Dinh and others
JNCI: Journal of the National Cancer Institute, Volume 116, Issue 3, March 2024, Pages 455–467, https://doi.org/10.1093/jnci/djad236
Comparative cost-effectiveness of contemporary treatment strategies for stage IIA seminoma
Daniel D Joyce and others
JNCI: Journal of the National Cancer Institute, Volume 116, Issue 3, March 2024, Pages 468–475, https://doi.org/10.1093/jnci/djad211
Disparities in electronic health record portal access and use among patients with cancer
Joan M Griffin and others
JNCI: Journal of the National Cancer Institute, Volume 116, Issue 3, March 2024, Pages 476–484, https://doi.org/10.1093/jnci/djad225
Brief Communication
Incarceration and screen-detectable cancer diagnosis among adults in Connecticut
Ilana B Richman and others
JNCI: Journal of the National Cancer Institute, Volume 116, Issue 3, March 2024, Pages 485–489, https://doi.org/10.1093/jnci/djad242
Stat Bite
Cancer Death Rates By State
JNCI: Journal of the National Cancer Institute, Volume 116, Issue 3, March 2024, Page 490, https://doi.org/10.1093/jnci/djae005
Advertisement
Advertisement